XERS - Xeris Pharmaceuticals Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-06-05    (Delayed quote data   2025-09-15)
Last
 7.36		 Change
 ⇓ -0.13   (-1.74%)		 Volume
  1,494,403
Open
 7.49		 High
 7.53		 Low
 7.34
8EMA (Daily)
 7.63		 40EMA (Daily)
 6.96		 50EMA (Daily)
 6.73		 STO (Daily)
 28.971		 MACD Hist (Daily)
 -0.253
8EMA (Weekly)
 7.115		 40EMA (Weekly)
 5.22		 50EMA (Weekly)
 4.90		 STO (Weekly)
 91.237		 MACD Hist (Weekly)
 0.348
Company Profile
Xeris Pharmaceuticals Inc is a specialty pharmaceutical company leveraging its novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations. Its pipeline products are Diazepam, Pramlintide-Insulin, Self-Administered Glucagon, and others.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com